InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: Rymankoly post# 2283

Wednesday, 05/24/2017 8:05:47 AM

Wednesday, May 24, 2017 8:05:47 AM

Post# of 8305
Tonix Pharmaceuticals to Present Additional Clinical Results of Military-Related PTSD Study at the 2017 $TNXP. 

Target price of $31/share is nothing if the US government and the Military approve use of the drug to treat veterans.imo 

http://www.nasdaq.com/press-release/tonix-pharmaceuticals-to-present-additional-clinical-results-of-militaryrelated-ptsd-study-at-the-20170524-00320

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNXP News